Table 3: Patient characteristics.
Characteristics | Frequencies | |
Age (years) | ≤ 60 | 42 (60.9%) |
> 60 | 27 (39.1%) | |
LDH elevated | No | 7 (10.1%) |
Yes | 62 (89.9%) | |
Hemoglobin | ≥ 12 g/dL | 27 (39.1%) |
< 12 g/dL | 42 (60.9%) | |
Ann Arbor Stage | I | 1 (1.4%) |
II | 13 (18.8%) | |
III | 31 (44.9%) | |
IV | 24 (34.8%) | |
No. of nodal areas | ≤ 4 | 32 (46.4%) |
> 4 | 37 (53.6%) | |
Extranodal involvement | 2 (2.9%) | |
Grade | 1 | 18 (26.08%) |
2 | 32 (46.4%) | |
3A + 3B | 19 (27.5%) | |
FLIPI Risk groups | I | 7 (10.1%) |
II | 12 (17.4%) | |
III | 50 (72.5%) | |
BM | Yes | 13/69 (18.8%) |
No | 53/69 (76.8%) | |
BX | Yes | 21/69 (30.4%) |
No | 46/69 (66.7%) | |
Circulating lymphoma cells | Yes | 7/69 (10.1%) |
No | 62/69 (89.9%) |
BX: Bone marrow biopsy; BM: Bone marrow aspiration